Jefnan1 wrote: Muggy, you are correct in your reasoning for staying here. Do you know what the first thing they said they would be advising on in 22 and approx when. Happy NY to you

I think they are moving quickly into Acute Pain development work - that's the first order of business.
Then ... just guessing but I'd like to see a fast-track application at that point and an FDA answer within 60 days of applying.

CITA sale could come at any time in the 12 months since Sept 2021, based on IFRS 5 rules.  Don't think that is in stone though.